Ann: Phosphagenics Arbitration Award Issued, page-115

First 115 Last

Share
Profile

Follow
Melos

198 Posts.

36

12/11/18

18:26

Post #: 36475083
Share

Originally posted by jsbuser ↑

I was out on open for 0.06c but I only had punt money in this time, still a chunk but controlled myself. I'd lost far too much in previous years to think POH management bringing this home was a given. Sorry for the long stagers who have taken hit after hit here.

Anyway, where to from here? People need to dust themselves off and start to look objectively at things.

The company is worth something:
1. Agreements are in place, although ponderously sketchy, so that has value
2. IP & Patents are probably worth something, so that has value
3. Company structure, even as a bio shell is worth something, so that has value
4. Any royalties from Dapto etc, if they can afford to chase them
5. Running costs can be slashed to someone targeted at realising value out of items 1 to 4 above, so that has value if they can lean off to say 1 person

Against that are the costs of litigation and any awarding of costs for Mylan. Of course this could sink the company but perhaps some scheme can worked out. So where do you end up with this? Is there enough in 1 to 5 to cover the costs?

I cant see any other rabbits left in the hat right now. Any ideas?

I certainly will be evaluating entry into any Oz bio with a very jaundiced eye from now on. You spend ten years getting played, management are scant on talent, and then you get eaten up by the whales for peanuts.

Sorry sentiment None Not Held

Expand

I was holding $2500 worth of this garbage glad i sold out at a 10% loss before this news hit. I really do feel sorry for the holders.

This stock should have their code changed to Poo

POH Price at posting: 0.3¢ Sentiment: Sell Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

RC1

Firebrick Pharma launching retail Nasodine sales in Singapore

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 146 more messages in this thread...

First 115 Last

Add POH (ASX) to my watchlist

(20min delay)
Last 0.0¢		Change 0.000(0.00%)		Mkt cap ! n/a

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Phosphagenics Arbitration Award Issued, page-115

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Firebrick Pharma launching retail Nasodine sales in Singapore

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Featured News

Featured News

Ann: Phosphagenics Arbitration Award Issued, page-115

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Firebrick Pharma launching retail Nasodine sales in Singapore

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Featured News

Featured News